FIELD: medicine; pharmaceuticals.
SUBSTANCE: invention relates to the pharmaceutical industry and provides the use of sulphated hyaluronic acid for topical application as a stimulant of cutaneous absorption of pharmacologically and / or biologically active agents, wherein said sulphated hyaluronic acid (HA) has a molecular weight in the range of 10,000 to 50,000 Da, from 150,000 to 250,000 Da, or from 500,000 to 750,000 Da, and a degree of sulphation equal to 1 or 3.
EFFECT: invention provides stimulation of cutaneous absorption of active agents, in particular non-steroidal anti-inflammatory drugs.
8 cl, 15 dwg, 32 ex
